1 / 39

DIABETES IN PREGNANCY

DIABETES IN PREGNANCY. BY DR. SHUMAILA ZIA. DIABETES IN PREGNANCY. INCIDENCE -- 3—4/1000 pregnancy. CARBOHYDRATE METABOLISM DURING PREGNANCY:. Increased tissue resistance to insulin. Normally glucose level stays constant b/w 4-4.5 mmol/l except after meals.

tuesday
Télécharger la présentation

DIABETES IN PREGNANCY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. DIABETES IN PREGNANCY BY DR. SHUMAILA ZIA

  2. DIABETES IN PREGNANCY INCIDENCE -- 3—4/1000 pregnancy.

  3. CARBOHYDRATE METABOLISM DURING PREGNANCY: • Increased tissue resistance to insulin. • Normally glucose level stays constant b/w 4-4.5 mmol/l except after meals. • With increasing insulin resistance, homeostasis can only be maintained by doubling insulin secretion from the end of 1st to 3rd trimester b/c insulin resistance increases with gestation. • Exact etiology unknown, most probably b/c of increased production of preg. associated hormones or free cortisol, like HPL (Human placental lactogen) most important.

  4. INFLUENCE OF PREGNANCY ON CHO MET. • Increased insulin resistance –increased production of insulin by pancreas (hyperplasia/ hypertrophy) • Adequate insulin production may become inadequate to meet increased demand during pregnancy –gestational DM • Abnormally high tissue insulin resistance. 2. Known diabetic controlled on diet may need insulin 3. Medicine dependent need enhanced medication.

  5. CHO. DERANGEMENTS IN PREGNANCY • Established DM: - Type- 1----IDDM (more common in peg.) - Type- 2----NIDDM 2. Gestational DM: - Appear in preg. mostly disappear after preg. 3. Impaired Glucose tolerance: - CHO metabolism altered - Some develop frank DM in later half - So, should be managed as DM

  6. White’s classification Class D Insulin-treated diabetic Onset under age 10 Duration more than 20 years Background retinopathy Class F Diabetic nephropathy Class H Cardiac disease Class R Proliferative retinopathy Class A1 Abnormal glucose tolerance test with normal fasting capillary (95 mg/dl) and postprandial (120 mg/dl) glucose levels Controlled with diet alone Class A2 Abnormal glucose tolerance test with abnormal fasting or postprandial glucose levels Treated with diet and insulin Class B Insulin-treated diabetic Onset over age 20 years Duration less than 10 years No vascular disease or retinopathy Class C Insulin-treated diabetic Onset between ages 10 and 20 years Duration between 10 and 20 years Background retinopathy

  7. EFFECTS OF DM ON PREGNANCY • Fetal glucose level follows maternal one closely until facilitated diffusion saturated or maternal glucose reaches 11-13mmol/l then fetus dose not follow—Fetal protective mechanism • Insulin appear in fetal circulation at 10-12 wk. • In maternal DM, fetus has hyperinsulinemia- acting as growth promoting hormone-- fetal macrosomia • F. hyperinsulinemia rather than F. hyperglycemia is responsible for adverse effects.

  8. ADVERSE FETAL EFFECT OF DM. • Congenital Malformation: 4—10 times higher than normal. Exact mechanism of teratogenicity not known. Said to be directly related to conc. Of glucose at time of organogenesis. So, in known diabetics ---more chance of Cong. abnormality.

  9. ADVERSE FETAL EFFECT OF DM. Cont-- • Structural abnormalities: CVS, Skeletal, CNS, GIT. • Fetal caudal regression syndrome: Abnormality of vertebrae below T10. • Sacral agenesis: missing sacrum. • Dislocation of hips. • Talipes. • Spina bifida. • Renal anomalies. • Urinary or fecal incontinence.

  10. Cong. An. of infants of diabetic mother • Skeletal and central nervous system Caudal regression syndrome Neural tube defects Microcephaly • Cardiac Transposition of the great vessels Ventricular septal defects Coarctation of the aorta defects or patent ductus arteriosus Atrial septal defects Cardiomegaly • Renal • Hydronephrosis • Renal agenesis • Urethral duplication • Gastrointestinal • Duodenal atresia • Anorectal atresia • Small left colon syndrome • Other • Single umbilical artery

  11. ADVERSE FETAL EFFECT OF DM. Cont-- 2.Spontaneous miscarriage: Due to cong. Anomalies. 3.Fetal macrosomia: - Due to f. hyperinsulinaemia. body wt 4kg. - f. macrosomia----large for dates. - Prolonged obstructed labour. - Shoulder dystosia. 4.IUGR: - placental function compromised. - poor prognosis.

  12. ADVERSE FETAL EFFECT OF DM. Cont-- 5. Polyhydramnios: - fetal. polyuria—osmotic diuresis. - premature labour. - malpresentation. 6.Pre-eclempsia: - perinatal mortality double. 7.RDS: - diabetes delays production of surfactant. 8. Unexplained intrauterine death. 9. Perinatal mortality: - 5times higher.

  13. Infant of diabetic mother.

  14. MANAGEMENT. • INITIAL MANAGEMENT: A:known diabetic: - Pre-pregnancy care - Early booking --- optimal control --- USG B:Gestational diabetes: - Many women go unrecognized &diagnosed after poor obs. Outcome.

  15. EFFECTS OF PREGNANCY ON DM CONTROL More difficult RETINOPATHY Proliferative retinopathy may progress so careful ophthalmic assessment. NEPHROPATHY • No permanent deterioration in renal function. • Fetal outcome good if preclampsia does not supervene & glucose control good. • End stage renal disease – termination of pregnancy.

  16. INITIAL MANAGEMENT Cont-- SCREENING: a. Clinical Features: cheap way of screening. women at high risk of gest. D.M. *diabetes in 1st degree relatives. *maternal obesity. Wt.90kg. *persistent glycosuria. * previous hx. of large baby. *previous hx. of unexplained still birth. *previous birth of cong. malformed baby. *polyhydramnios /macrosomia in current preg.

  17. INITIAL MANAGEMENT Cont-- b. Random glucose test. cut of value 6.4 mmol/l with in 2 hr& 5.8mmol/l after 2 hrs of meal-----OGTT. c. Fasting glucose test. cut of value 4.8mmol/l-----OGTT. d. Glucose challenge test: At 28wks. 50g glucose given. 1hr later blood taken--if >7.8mmol/l-OGTT.

  18. DIAGNOSTIC TEST. • Oral glucose tolerance test. Gold standard investigation. If screening test is +v O’SULLIVAN METHOD. - after an overnight fast >8hrs. - a fasting blood sample taken. - Give 100g glucose in 250ml water. - Take blood sample ½ hrly for next 3 hrs.

  19. Abnormal results: if values exceeds this: fasting= 5.0mmol/l 1hr = 9.2mmol/l 2hr = 8.1mmol/l 3hr = 6.9mmol/l

  20. WHO OGTT75 grams glucose in 250ml water after fasting sample

  21. II. Further Management. • Medical management. • Obstetrical management. MEDICAL MANAGEMENT: combined care –obstetrician + endocrinologist. a) TREATMENT MODLITIES: - diet. - diet + insulin.

  22. 1. Diet: Three meals and three snacks 30-35 Kcal/Kg ideal body weight No more than 10-12 Kg weight gain 50% of energy carbohydrates (unrefined), 30% fat and 20% proteins Review diet history to identify major areas of reduction of caloric intake Insulin: see later Alert the patients and relatives about the possibility of hypoglycemia and measures to counteract

  23. 2.INSULIN THERAPY. • Tm of choice - does not cross placenta. - Short acting. - Long acting. • Insulin regimen: • four times daily regimen; - short acting insulin---3 times after meal. - long acting---------------at night.

  24. 2.INSULIN THERAPY Cont-- BIPHASIC REGIMEN: • Fixed combination of medium & short acting insulin 70:30 is given in 2DD dosage. • One before breakfast and other before dinner • 2/3rd of daily dose before breakfast.2/3-p.insulin+1/3-NPH. • 1/3rd in evening.1/2+ 1/2. p.insulin+NPH.

  25. DOSAGE SCHEDULE • In insulin dependent, adjust dose especially in later half of pregnancy • If started during preg. Initially start 6 hourly short acting 6 units/dose but at night long acting 10 units For biphasic regimen start 20units/day • In NIDDM control on diet, start insulin if Pre-prandial glucose persistantly > 6mmol/l

  26. OTHER FORMULAS TO CONTROL DIABETES. 1.wt× 0.7------6_15 wks. Wt× 0.8 ---15_25wks wt×0.9 ---25_35wks. Wt×1 u----36-40 wks. 2.wt/2. total dose. 3. Sliding scale. 4. BSL -5/20= single dose. 5. Mean of all readings of bld sugar profile/5.

  27. MONITORING • Objective is to maintain - Fasting glucose------< 5.5 mmol/l - P P ---------------------<7.5 mmol/l a. Blood glucose level: - In U K ---- test 4 times (3 pre-meal & 1 at bed time) - In U S A – after meal measurements also taken b/c it correlate better with fetal wt. - Pre-breakfast high measurement may be due to rebound phenomenon after nocturnal hypoglycemia

  28. b. HbA1C (glycosilated Hb.): Glucose irreversibly bound to Hb. - Indicates previous 2 months glucose control - Repeat monthly basis - For good control should be <8%.

  29. OBSTETRICAL MANAGEMENT • ANTENETAL CARE: • -1ST trimester : - good glucose control & - USG - 2nd trimester: - USG at 18-20 wk.(cong. An.) - USG at 20-22wk.(cardiac An.) - 3rd trimester: - Care for . Polyhydramnios . PIH . F. macrosomia . IUD . Pre-term labour

  30. 2. DELIVERY: a) Time of Delivery: - Well controlled DM --- 39-40 weeks - Uncontrolled DM ----- 38 weeks b) Mode of Delivery: - Vaginal delivery is mode of choice - Low threshold for C- section

  31. c) Management During Labour: *Insulin therapy: Give I/V insulin 1 unit/h if, . Labour established . Induction of labour . Elective C-section Dilute insulin 20 U (0.2ml) in 19.8 ml N/S . Infuse 1 ml (1 U)/ hour. Measure glucose 1 hourly Aim: Maintain glucose between 4.5-5.5 mmol/l Give also 10% D/W in other I/ V line @ 1L/8 hourly

  32. * OBSTETRIC Mx:- Induction of labour – as usual - good pain relief - avoid milking of U cord - Early clamping of U cord - call neonatologist

  33. 2. VISIT FREQUENCY: -Fortnightly from 24-32 wk. followed by weekly 3. FETAL SURVEILLANCE: a) USG: - AC– good indicator of fetal wt. so, - AC+ AFI from 24 weeks , fortnightly b) CTG: - 2-3 times/week from 36 weeks onward c) Doppler: d) Biophysical Profile:

  34. POST PARTUM CARE • CARE OF THE MOTHER • Fall in insulin requirement in the puerperium. • CARE OF THE BABY • RESPIRATORY SYSTEM • Resp distress syndrome • Transient tachypnoea of the newborn • HYPOGLYCAEMIA • Blood glucose checked at 2,4,6& 12 hours of age. • If <1.4mmol/l at 4 hours, I/v 10% dextrose. • Start feeding by 2 hours & continue at 3-4 hours interval. • HYPERBILI RUBINAEMIA • Vit K 1mg Inj. • Phenobarbitone 2.5-5mg /kg daily • Phototherapy • Exchange transfusion

  35. NEWBORN MAANAGEMENT • SERIALLY ASSESS CAPILLARY GLUCOSE OF THE NEONATE ESPECIALLY IN THE FIRST 12 HOURS. REPLACE GLUCOSE IF THE GLUCOSE LEVEL IS LESS THAN 45 MG/DL • IF THE HEMATOCRIT VALUE EXCEEDS 70, EXCHANGE TRANSFUSION • SERIALLY MONITOR BILIRUBIN LEVEL.

  36. CONTRACEPTION • Estrogen containing allowed with need for tight control unless vascular disease • Progestin only allowed • IUCD allowed increased method failure • Barrier methods allowed • Sterilization should be considered especially women with contraindications to pregnancy (proliferative retinopathy, cardiopathy, nephropathy, gastropathy and other vascular lesions)

  37. DON’T FORGET • OGTT at 6 weeks to confirm disappearance of impaired glucose tolerance

  38. SUMMARY • DM is a common and serious problem for the mother and fetus • Prompt management of preexisting DM should start BEFORE pregnancy • Insulin dosage schemes differ but the therapeutic aim is the same • GDM should be sought in all pregnant women with few exceptions

  39. THANK YOU

More Related